Tuberous Sclerosis

We are one of the few pharmacies in North America that make topical rapamycin (sirolimus) ointment in strengths ranging from 0.1-0.35%. It has been successfully used in the treatment of facial angiofibromas in patients with Tuberous Sclerosis Complex. Facial angiofibromas have been historically resistant to medical, surgical and laser treatments. Topical application of rapamycin has shown to be an effective treatment, with minimal side effects.